• 1. Multiple strategies towards high-efficiency white organic light-emitting diodes by the vacuum deposition method
  Hui Liu,Futong Liu,Ping Lu J. Mater. Chem. C 2020 8 5636
• 2. Synthesis, electrochromic, halochromic and electro-optical properties of polyazomethines with a carbazole core and triarylamine units serving as functional groups
  Xiaochuan Ma,Haijun Niu,Hailin Wen,Shuhong Wang,Yongfu Lian,Xiankai Jiang,Cheng Wang,Xuduo Bai,Wen Wang J. Mater. Chem. C 2015 3 3482
• 3. Polydiphenylamine as a promising high-energy cathode material for dual-ion batteries
  Filipp A. Obrezkov,Alexander F. Shestakov,Sergey G. Vasil'ev,Keith J. Stevenson,Pavel A. Troshin J. Mater. Chem. A 2021 9 2864
• 4. A comparative study of redox-active, ambipolar electrochromic triphenylamine-based polyimides prepared by electrochemical polymerization and conventional polycondensation methods
  Sheng-Huei Hsiao,Wei-Kai Liao,Guey-Sheng Liou Polym. Chem. 2018 9 236
• 5. Construction of a fully conjugated cross-linked hole-transport film based on ethynyl to enable high mobility for efficient solution-processed OLEDs
  Cancan Peng,Hongli Liu,Xinjun Han,Fei Zhang,Shirong Wang,Xianggao Li J. Mater. Chem. C 2022 10 14471

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Recent Advances in the Study of 4-(4-Anilinophenyl)-N-phenyl-aniline (CAS: 531-91-9) in Chemical Biology and Pharmaceutical Research

The compound 4-(4-anilinophenyl)-N-phenyl-aniline (CAS: 531-91-9) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, biological activity, and potential applications in drug development. The compound's distinct aromatic structure and electron-rich properties make it a promising candidate for various biomedical applications, including as a building block for advanced materials and as a potential therapeutic agent.

Recent studies have explored the synthesis and optimization of 4-(4-anilinophenyl)-N-phenyl-aniline, with a particular emphasis on improving yield and purity. Advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize the compound and ensure its structural integrity. These efforts have led to the development of more efficient synthetic routes, which are critical for scaling up production for preclinical and clinical studies.

In terms of biological activity, preliminary investigations have revealed that 4-(4-anilinophenyl)-N-phenyl-aniline exhibits notable interactions with specific cellular targets, including kinases and G-protein-coupled receptors (GPCRs). These interactions suggest potential applications in the treatment of diseases such as cancer and neurodegenerative disorders. For instance, recent in vitro studies have demonstrated the compound's ability to inhibit the proliferation of certain cancer cell lines, highlighting its potential as an anticancer agent. Further mechanistic studies are underway to elucidate the precise molecular pathways involved.

Another area of interest is the compound's role in the development of organic electronic materials. Due to its conjugated aromatic system, 4-(4-anilinophenyl)-N-phenyl-aniline has been investigated for use in organic light-emitting diodes (OLEDs) and other optoelectronic devices. Researchers have reported that the compound exhibits excellent charge transport properties, making it a viable candidate for next-generation electronic materials. These findings open up new avenues for interdisciplinary research at the intersection of chemistry, biology, and materials science.

Despite these promising developments, challenges remain in the clinical translation of 4-(4-anilinophenyl)-N-phenyl-aniline. Issues such as bioavailability, toxicity, and pharmacokinetics need to be addressed through comprehensive preclinical studies. Recent efforts have focused on modifying the compound's structure to enhance its drug-like properties while maintaining its biological activity. Computational modeling and structure-activity relationship (SAR) studies have been instrumental in guiding these modifications.

In conclusion, 4-(4-anilinophenyl)-N-phenyl-aniline (CAS: 531-91-9) represents a versatile compound with significant potential in both therapeutic and material science applications. Ongoing research is expected to further elucidate its mechanisms of action and optimize its properties for specific applications. The interdisciplinary nature of this research underscores the importance of collaboration between chemists, biologists, and material scientists to fully realize the compound's potential. This brief highlights the need for continued investment in research and development to overcome existing challenges and unlock new opportunities for this promising compound.

• 102113-98-4(Bis-Biphenyl-4-yl-amine)
• 10311-61-2(N,N'-Di-p-tolylbenzidine)
• 863012-93-5([1,1'-BIPHENYL]-4-AMINE, 4'-METHYL-N-(4-METHYLPHENYL)-)
• 147678-90-8(N-(p-Tolyl)-1,1'-biphenyl-4-amine)
• 32228-99-2(N-Phenyl-4-biphenylamine)
• 149711-54-6([1,1':3',1''-TERPHENYL]-4,4''-DIAMINE, N,N'-DIPHENYL-)
• 897671-81-7(4-Anilino-1,1':4',1''-terphenyl)
• 147951-36-8(1,3,5-Tris[4-(diphenylamino)phenyl]benzene)
• 128049-24-1(p-phenylenediamine, n,n'-bis(p-biphenylyl)-)
• 897921-63-0(4-Phenyl-N-[4-(4-phenylphenyl)phenyl]aniline)